San Francisco Employees Retirement System Commits to Three Biotech Venture Funds
SFERS is enduring a tough 2022, thanks to steep
declines in public markets and fixed income portfolios.
SFERS is enduring a tough 2022, thanks to steep
declines in public markets and fixed income portfolios.
Battery Ventures, New Mountain, Threshold and ArchiMed are among those backed.